HealthTell Wins $225K SBIR Grant for Brain Cancer Dx Work | GenomeWeb

NEW YORK(GenomeWeb) – HealthTell said today that it has received a $225,000 SBIR grant from the National Institutes of Health.

The funds will support work to evaluate the effectiveness of the company's immunosignature technology in the diagnosis of brain cancer, and glioblastoma multiforme, specifically.

According to HealthTell, the company aims through the project to demonstrate its platform's ability to distinguish primary brain cancers from brain cancers arising as metastases from other sites; and to differentiate brain cancer subtypes and grades of malignant gliomas.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.